E-Mail Updates

Click here to join
our Electronic Communications.

Listen to our latest webcast
“Immutep to Present at Ladenburg Thalmann 2018 Healthcare Conference ”
from October 2nd, 2018

Upcoming Events.


October 19th 2018 - October 23rd 2018

Representatives of the company will be attending the conference.

Venue:   Messe Munich, Messegelände, 81823 Munich, Germany, www.messe-muenchen.de

October 24th 2018 - October 27th 2018

Dr. Victoria Atkinson (Principal Investigator TACTI-mel) speaks on the subject:

"Results from a Phase I dose escalation trial (TACTI-mel) with the soluble LAG-3 protein (IMP321, eftilagimod alpha) together with pembrolizumab in unresectable or metastatic melanoma."

Venue: Manchester Central Convention Complex, Manchester, United Kingdom

October 30th 2018

Marc Voigt, CEO of Immutep, will present a corporate overview and business update.

Venue: Sofitel Melbourne on Collins, Melbourne VIC 3000, Australia

click here to view program of the event

November 7th 2018 - November 11th 2018

The company will have presentations at the conference and representatives will be attending.

Venue:    Walter E. Washington Convention Center, 801 Mt Vernon Pl NW, Washington, D.C., DC 20001, USA

November 8th 2018

Marc Voigt, CEO of Immutep, will present a corporate overview and business update.

Venue: Macquarie Office -  Sydney, Australia

click here for agenda

November 16th 2018
November 27th 2018 - November 29th 2018

conference day 1/ 02.00 p.m.

Frédéric Triebel, CSO & CMO of Immutep speaks on the subject:

Two ACTIve Immunotherapies (TACTI): Results of Phase I Trial With Metastatic Melanoma Patients (TACTI-mel) Treated With a Soluble LAG-3 Receptor (LAG-3lg or Eftilagimod Alpha) as an Antigen Presenting (APC) Activator Combined with Pembrollzumab

Venue: The Sofitel Berlin Kurfuerstendamm, Berlin, Germany

January 7th 2019 - January 10th 2019

37th Annual J.P. Morgan Health Care Investor Conference

Venue:    San Francisco, California, USA

Past Events.


October 19th 2018 - October 23rd 2018

Representatives of the company will be attending the conference.

Venue:   Messe Munich, Messegelände, 81823 Munich, Germany, www.messe-muenchen.de

October 2nd 2018

Immutep to Present at Ladenburg Thalmann 2018 Healthcare Conference

Marc Voigt, CEO of Immutep, is scheduled to present a corporate overview and business update at 3:30pm ET on Tuesday, October 2, 2018, with one-on-one meetings held throughout the day. The presentation will be webcast live and available for replay via the investor relations section of the company’s website at www.immutep.com.

Listen to the webcast “Immutep to Present at Ladenburg Thalmann 2018 Healthcare Conference”

Download "Ladenburg 2018 HC Conference Immutep Presentation"

September 7th 2018

BioCentury 25th Annual NewsMakers - Biotech Industry Conference

Marc Voigt, CEO of Immutep, will present a corporate overview and business update with one-on-one meetings held throughout the day. 

Venue:  Millenium Broadway Hotel & Conference Center, NY, USA

Press release: click here

Download "Newsmaker Immutep Corporate Presentation"

Listen to the webcast “Immutep Newsmakers Presentation” from September 7th, 2018

 

Finance News Network - Interview with Marc Voigt (CEO), 06.09.18

FNN – Interview with Immutep

Sky Business News - Interview with Marc Voigt (CEO), 30.04.18

Interview with Frédéric Triebel and Marc Voigt

CNBC - Interview with Marc Voigt (CEO)

Sky Business News - Interview with Marc Voigt (CEO), 25.11.15

The Business - Interview with Lucy Turnbull

Sky Business News - Interview with Marc Voigt (CEO), 16.05.14